Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1985-12-02
1987-12-22
Kight, John
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530405, 530389, 530403, 530404, 530402, 530390, 424 88, 424 92, 424 91, 514885, 514829, 514389, C07K 1700, C07K 1500
Patent
active
047147598
ABSTRACT:
A product and process for treating allergy are described. An immunotoxin specific for the IgE isotype is used to eliminate the IgE producing B-lymphocytes responsible for allergy.
REFERENCES:
patent: 4564600 (1986-01-01), Ali
patent: 4661347 (1987-04-01), Muller
Killen et al, J. Immunol., 133, 1984, pp. 2549-2553.
Jansen et al, Immunological Rev., 62, 1982, pp. 185-216.
Vitetta et al, Immunol. Rev., 62, 1982, pp. 159-183.
Vallera et al, J. Exp. Med., 155, 1982, pp. 949-954.
Farkas et al, Immunol., 45, 1982, pp. 483-492.
Masuho et al, J. Biochem, 91, 1982, pp. 1583-1591.
Ramakrishnon et al, Cancer Res., 44, 1984, pp. 201-208.
Draper Garnette D.
Kight John
LandOfFree
Immunotoxin therapy of allergy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotoxin therapy of allergy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotoxin therapy of allergy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-819364